Thiazolidinediones and antiblastics in primary human anaplastic thyroid cancer cells-Reference-Cited by-同舟云学术

Thiazolidinediones and antiblastics in primary human anaplastic thyroid cancer cells

Published:2009-06 Issue:6 Volume:70 Page:946-953
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:

Author:

Antonelli Alessandro,Ferrari Silvia Martina,Fallahi Poupak,Berti Piero,Materazzi Gabriele,Minuto Michele,Giannini Riccardo,Marchetti Ivo,Barani Lucio,Basolo Fulvio,Ferrannini Ele,Miccoli Paolo

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.2008.03415.x/fullpdf

Reference45 articles.

1. Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches;Ain;Thyroid,1998

2. Anaplastic thyroid carcinoma: current diagnosis and treatment;Giuffrida;Annals of Oncology,2000

3. Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy;Junor;European Journal of Surgical Oncology,1992

4. Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single institution in the past 5 years;Brignardello;European Journal of Endocrinology,2007

5. Clinical experience of the multimodality management of anaplastic thyroid cancer and literature review;Pudney;Thyroid,2007

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN–ALK Fusion In Vitro;International Journal of Molecular Sciences;2024-06-19

2. Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs;Frontiers in Pharmacology;2023-12-11

3. Neutrophil extracellular traps and neutrophil-related mediators in human thyroid cancer;Frontiers in Immunology;2023-08-29

4. Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture;International Journal of Molecular Sciences;2023-01-25

5. Molecular features of aggressive thyroid cancer;Frontiers in Oncology;2022-12-20